Focus and Scope
JMIR Diabetes focuses on technologies, medical devices, apps, engineering, informatics and patient education for diabetes prevention, self-management, care, and cure, to help people with diabetes. JMIR Diabetes may consider papers that do not have a digital health component but represent a significant innovation for diabetes prevention and care.
JMIR Diabetes publishes original research, viewpoints, and reviews (both literature reviews and medical device/technology/app reviews) covering, for example, wearable devices and trackers, mobile apps, glucose monitoring (including emerging technologies such as Google contact lens), medical devices for insulin and metabolic peptide delivery, closed loop systems and artificial pancreas, telemedicine, web-based diabetes education and elearning, innovations for patient self-management and "quantified self", diabetes-specific EHR improvements, clinical or consumer-focused software, diabetes epidemiology and surveillance, crowdsourcing and quantified self-based research data, new sensors and actuators to be applied to diabetes.
As an Open Access journal, JMIR Diabetes is read by clinicians and patients alike and has (as all JMIR Publications journals) a focus on readable and applied science reporting the design and evaluation of health innovations and emerging technologies, as well as on diabetes prevention and epidemiology.
JMIR Diabetes is indexed in PubMed, PubMed Central, DOAJ, Scopus and the Web of Science™ (ESCI) and may receive its inaugural journal impact factor as early as 2025.